Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773617 · ClinicalTrials.gov registry record · NA
Testing an Alternative Therapy for Bulimia Nervosa
A NA study, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00773617: Completed NA study, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
NCT00773617 is a NA study that has completed, run by Neuropsychiatric Research Institute, Fargo, North Dakota. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00773617, a NA study, has completed, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will compare a new method of treatment for bulimia nervosa (ICAT), integrative cognitive-affective therapy, to the current standard method of treatment, cognitive behavioral therapy (CBT).
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL ICAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT00773617 record still lists
NCT00773617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which CBT is the first listed.
NCT00773617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00773617 about?
NCT00773617 is a clinical study titled "Testing an Alternative Therapy for Bulimia Nervosa". This study will compare a new method of treatment for bulimia nervosa (ICAT), integrative cognitive-affective therapy, to the current standard method of treatment, cognitive behavioral therapy (CBT).
What is the current status of trial NCT00773617?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2009-03. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00773617?
The interventions under investigation include: CBT (BEHAVIORAL), ICAT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00773617?
This trial is sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00773617's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia